Search Results

Effects of Escherichia coli lipopolysaccharide on the metformin pharmacokinetics in rats

Authors: Cho, Y. K.; Choi, Y. H.; Kim, S. H.; Lee, M. G.

Source: Xenobiotica, Volume 39, Number 12, December 2009 , pp. 946-954(9)

Publisher: Informa Healthcare

Validated LC-MS-MS Method for the Determination of Gabapentin in Human Plasma: Application to a Bioequivalence Study

Authors: Wattananat, Triporn; Akarawut, Wiyada

Source: Journal of Chromatographic Science, Volume 47, Number 10, November/December 2009 , pp. 868-871(4)

Publisher: Preston Publications

Long-standing hidradenitis suppurativa treated effectively with metformin

Authors: Arun, B.; Loffeld, A.

Source: Clinical & Experimental Dermatology, Volume 34, Number 8, December 2009 , pp. 920-921(2)

Publisher: Blackwell Publishing

Gastroretentive Drug Delivery of Metformin Hydrochloride: Formulation and In Vitro Evaluation Using 32 Full Factorial Design

Authors: Boldhane, Sanjay P.; Kuchekar, Bhanudas S.

Source: Current Drug Delivery, Volume 6, Number 5, October 2009 , pp. 477-485(9)

Publisher: Bentham Science Publishers

Long-term glycaemic effects of pioglitazone compared with placebo as add-on treatment to metformin or sulphonylurea monotherapy in PROactive (PROactive 18)

Authors: Scheen, A. J.; Tan, M. H.; Betteridge, D. J.; Birkeland, K.; Schmitz, O.; Charbonnel, B.

Source: Diabetic Medicine, Volume 26, Number 12, December 2009 , pp. 1242-1249(8)

Publisher: Blackwell Publishing

Metformin increases plasma ghrelin in Type 2 diabetes

Authors: Doogue, Matthew P.; Begg, Evan J.; Moore, M. Peter; Lunt, Helen; Pemberton, Chris J.; Zhang, Mei

Source: British Journal of Clinical Pharmacology, Volume 68, Number 6, December 2009 , pp. 875-882(8)

Publisher: Blackwell Publishing

Type 2 diabetes mellitus with pancreatic β cell dysfunction in 3 horses confirmed with minimal model analysis

Authors: Durham, A.E.; Hughes, K.J.; Cottle, H.J.; Rendle, D.I.; Boston, R.C.

Source: Equine Veterinary Journal, Volume 41, Number 9, December 2009 , pp. 924-929(6)

Publisher: Equine Veterinary Journal Ltd.

Diabetic Medications in Pregnancy

Authors: Young, James; Anwar, Aresh

Source: Current Diabetes Reviews, Volume 5, Number 4, November 2009 , pp. 252-258(7)

Publisher: Bentham Science Publishers

New developments in incretin-based therapies: The current state of the field

Author: Robertson, Carolyn

Source: Journal of the American Academy of Nurse Practitioners, Volume 21, Supplement 1, November 2009 , pp. 631-641(11)

Publisher: Blackwell Publishing

Optimizing outcomes with incretin-based therapies: Practical information for nurse practitioners to share with patients

Author: Fleury-Milfort, Evelyne

Source: Journal of the American Academy of Nurse Practitioners, Volume 21, Supplement 1, November 2009 , pp. 642-650(9)

Publisher: Blackwell Publishing

Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once-weekly, human GLP-1 analogue, after single-dose administration in patients with Type 2 diabetes

Authors: Kapitza, C.; Heise, T.; Birman, P.; Jallet, K.; Ramis, J.; Balena, R.

Source: Diabetic Medicine, Volume 26, Number 11, November 2009 , pp. 1156-1164(9)

Publisher: Blackwell Publishing

Alogliptin Use in Elderly People: A Pooled Analysis from Phase 2 and 3 Studies

Authors: Pratley, Richard E.; McCall, Thérèse; Fleck, Penny R.; Wilson, Craig A.; Mekki, Qais

Source: Journal of the American Geriatrics Society, Volume 57, Number 11, November 2009 , pp. 2011-2019(9)

Publisher: Blackwell Publishing

Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies

Authors: Bushe, C. J.; Bradley, A. J.; Doshi, S.; Karagianis, J.

Source: International Journal of Clinical Practice, Volume 63, Number 12, December 2009 , pp. 1743-1761(19)

Publisher: Blackwell Publishing

Ultra-performance hydrophilic interaction LC-MS/MS for the determination of metformin in mouse plasma

Authors: Hsieh, Yunsheng; Galviz, Gerica; Hwa, Joyce J

Source: Bioanalysis, Volume 1, Number 6, September 2009 , pp. 1073-1079(7)

Publisher: Future Science

Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes

Authors: Derosa, G.; Tinelli, C.; Maffioli, P.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 12, December 2009 , pp. 1091-1099(9)

Publisher: Blackwell Publishing

Six-month outcomes on A1C and cardiovascular risk factors in patients with type 2 diabetes treated with exenatide in an ambulatory care setting

Authors: Brixner, D. I.; McAdam-Marx, C.; Ye, X.; Boye, K. S.; Nielsen, L. L.; Wintle, M.; Misurski, D.; Fabunmi, R.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 12, December 2009 , pp. 1122-1130(9)

Publisher: Blackwell Publishing

The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics

Authors: Kazda, C.; Gallwitz, B.; Simó, R.; Guzmán, J. R.; Kraus, P.; Nicolay, C.; Rose, L.; Schernthaner, G.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 12, December 2009 , pp. 1131-1137(7)

Publisher: Blackwell Publishing

Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA_1c without causing weight gain or increased hypoglycaemia

Authors: Rosenstock, J.; Rendell, M. S.; Gross, J. L.; Fleck, P. R.; Wilson, C. A.; Mekki, Q.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 12, December 2009 , pp. 1145-1152(8)

Publisher: Blackwell Publishing

Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue

Authors: Jendle, J.; Nauck, M. A.; Matthews, D. R.; Frid, A.; Hermansen, K.; Düring, M.; Zdravkovic, M.; Strauss, B. J.; Garber, A. J.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 12, December 2009 , pp. 1163-1172(10)

Publisher: Blackwell Publishing

The backbone of oral glucose-lowering therapy: time for a paradigm shift?

Author: Seufert, Jochen

Source: Fundamental & Clinical Pharmacology, Volume 23, Number 6, December 2009 , pp. 651-667(17)

Publisher: Blackwell Publishing